Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cyclin-dependent kinase 2 (Homo sapiens (Human)) | BDBM106952 (US8592581, 3) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet  | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 2 (Homo sapiens (Human)) | BDBM106950 (US8592581, 1) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 2 (Homo sapiens (Human)) | BDBM106953 (US8592581, 4) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 2 (Homo sapiens (Human)) | BDBM106958 (US8592581, 9) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 40 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 2 (Homo sapiens (Human)) | BDBM106956 (US8592581, 7) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 40 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 2 (Homo sapiens (Human)) | BDBM106960 (US8592581, 11) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 40 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 2 (Homo sapiens (Human)) | BDBM106955 (US8592581, 6) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 50 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 2 (Homo sapiens (Human)) | BDBM106959 (US8592581, 10) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 50 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 2 (Homo sapiens (Human)) | BDBM106961 (US8592581, 12) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 50 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 9 (Homo sapiens (Human)) | BDBM106952 (US8592581, 3) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 60 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 9 (Homo sapiens (Human)) | BDBM106953 (US8592581, 4) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 80 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 2 (Homo sapiens (Human)) | BDBM106950 (US8592581, 1) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 90 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 2 (Homo sapiens (Human)) | BDBM106965 (US8592581, 16) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 90 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 2 (Homo sapiens (Human)) | BDBM106952 (US8592581, 3) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 100 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 9 (Homo sapiens (Human)) | BDBM106950 (US8592581, 1) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 100 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 2 (Homo sapiens (Human)) | BDBM106953 (US8592581, 4) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 2 (Homo sapiens (Human)) | BDBM106957 (US8592581, 8) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 160 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 9 (Homo sapiens (Human)) | BDBM106960 (US8592581, 11) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 250 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 9 (Homo sapiens (Human)) | BDBM106955 (US8592581, 6) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 270 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 2 (Homo sapiens (Human)) | BDBM106963 (US8592581, 14) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 290 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 9 (Homo sapiens (Human)) | BDBM106956 (US8592581, 7) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 380 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 9 (Homo sapiens (Human)) | BDBM106957 (US8592581, 8) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 500 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 2 (Homo sapiens (Human)) | BDBM106951 (US8592581, 2) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 520 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 2 (Homo sapiens (Human)) | BDBM106964 (US8592581, 15) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 570 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 9 (Homo sapiens (Human)) | BDBM106958 (US8592581, 9) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 610 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 2 (Homo sapiens (Human)) | BDBM106962 (US8592581, 13) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 770 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 2 (Homo sapiens (Human)) | BDBM106954 (US8592581, 5) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 830 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 9 (Homo sapiens (Human)) | BDBM106959 (US8592581, 10) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.04E+3 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 9 (Homo sapiens (Human)) | BDBM106961 (US8592581, 12) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.04E+3 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 9 (Homo sapiens (Human)) | BDBM106965 (US8592581, 16) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.14E+3 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 2 (Homo sapiens (Human)) | BDBM106951 (US8592581, 2) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.25E+3 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 9 (Homo sapiens (Human)) | BDBM106951 (US8592581, 2) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.63E+3 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 9 (Homo sapiens (Human)) | BDBM106962 (US8592581, 13) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.84E+3 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 9 (Homo sapiens (Human)) | BDBM106963 (US8592581, 14) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 6.53E+3 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 9 (Homo sapiens (Human)) | BDBM106964 (US8592581, 15) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7.40E+3 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-dependent kinase 9 (Homo sapiens (Human)) | BDBM106954 (US8592581, 5) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7.89E+3 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Cyclacel Limited; Cancer Research Technology Limited US Patent | Assay Description To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u... | US Patent US8592581 (2013) BindingDB Entry DOI: 10.7270/Q25X27J9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
